OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 80 filers reported holding OCULAR THERAPEUTIX INC in Q4 2019. The put-call ratio across all filers is 0.24 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,650 | -57.9% | 22,500 | -30.8% | 0.01% | -57.9% |
| Q2 2023 | $167,700 | -84.7% | 32,500 | -84.3% | 0.02% | -86.0% |
| Q1 2023 | $1,094,178 | +43.8% | 207,624 | -23.3% | 0.14% | +33.3% |
| Q4 2022 | $760,645 | -49.6% | 270,692 | -25.6% | 0.10% | -50.2% |
| Q3 2022 | $1,510,000 | +183.3% | 363,844 | +174.3% | 0.20% | +225.4% |
| Q2 2022 | $533,000 | -13.2% | 132,654 | +80.0% | 0.06% | -25.0% |
| Q2 2020 | $614,000 | +314.9% | 73,678 | +145.6% | 0.08% | +250.0% |
| Q1 2020 | $148,000 | -16.9% | 30,000 | -33.3% | 0.02% | +33.3% |
| Q4 2019 | $178,000 | – | 45,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |